According to the safety findings, four Grade Five serious adverse events were reported during the Phase II PALIZADE trial.

William Blair analyst Matt Phipps in a note to investors wrote that despite the patient deaths, the totality of the data ...

Lupus nephritis progression may be faster in patients with interstitial fibrosis/tubular atrophy (IFTA). Now a nomogram may predict it.

Positive topline results were announced from a phase 3 study of obinutuzumab in patients with lupus nephritis.

"Adicet Bio begins enrolling subjects in Phase I trial of autoimmune disease therapy" was originally created and published by ...

Kezar Life Sciences saw its share tumble more than 42% to 40.77 yesterday, after it revealed it was voluntarily pausing ...

KEZAR Life Sciences said on Monday it has paused a trial of its experimental drug for lupus to review safety data after four patients died in the mid-stage study. The San Francisco-based company said ...

Wells Fargo analyst Derek Archila assigned a Hold rating on Kezar Life Sciences (KZR – Research Report) yesterday and set a price target ...

Acute Tubulointerstitial Nephritis has been observed in patients taking PPIs ... Talicia should not be used in patients with ...

Israeli troops crossed the border for the first time since 2006 in a ground operation targeting Hezbollah. The Israeli military called for evacuations in southern Lebanon. As a Crisis Builds ...

The Australian Red Cross says demand for blood is at a 12-year high as it launches the trial of a new pop-up donor centre in regional Western Australia.